Search Within

FALLOPIAN TUBE CANCER

Advances in the Treatment of Ovarian Cancer Using PARP Inhibitors and the Underlying Mechanism of Resistance

Journal: Current Drug Targets
Volume: 21, Issue: 2
Page: 167-178
Authors: Ling Wang, Qi Wang, Yangchun Xu, Manhua Cui and Liying Han*

DNA Double Strand Break Repair - Related Synthetic Lethality

Journal: Current Medicinal Chemistry
Volume: 26, Issue: 8
Page: 1446-1482
Authors: Monika Toma, Tomasz Skorski* and Tomasz Sliwinski*

Currently Approved Poly (Adenosine Diphosphate-Ribose) Inhibitors in Ovarian Cancer: Current Status and Future Directions

Journal: Clinical Cancer Drugs
Volume: 5, Issue: 1
Page: 3-12
Authors: Gonzalo H. Giornelli and Pablo Mando*

Towards Prevention of Ovarian Cancer

Journal: Current Cancer Drug Targets
Volume: 18, Issue: 6
Page: 522-537
Authors: Aus Tariq Ali*

Pharmacological Profile and Pharmacogenomics of Anti-Cancer Drugs Used for Targeted Therapy

Journal: Current Cancer Drug Targets
Volume: 18, Issue: 5
Page: 499-511
Authors: Raffaele Di Francia*, Angela De Monaco, Mariangela Saggese, Giancarla Iaccarino, Stefania Crisci, Ferdinando Frigeri, Rosaria De Filippi, Massimiliano Berretta and Antonio Pinto

Aurora Kinase Inhibitors in Head and Neck Cancer

Journal: Current Topics in Medicinal Chemistry
Volume: 18, Issue: 3
Page: 199-213
Authors: Guangying Qi, Jing Liu, Sisi Mi, Takaaki Tsunematsu, Shengjian Jin, Wenhua Shao, Tian Liu, Naozumi Ishimaru, Bo Tang* and Yasusei Kudo*

Poly (ADP-Ribosyl) Polymerase 1 Inhibitors: A Patent Review

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 12, Issue: 3
Page: 208-220
Authors: Mengda Cao, Xi Sun, Yanjun Zhou, Wen Huang, Ling Meng* and Ji-Fu Wei*

Effective Strategies and Applications of Dendrimers in the Treatment of Ovarian Cancer

Journal: Current Pharmaceutical Design
Volume: 23, Issue: 21
Page: 3099-3104
Authors: Akila Kesavan, Suresh Babu Pakala, Suresh K. Rayala* and Ganesh Venkatraman*

The Benefits and Side Effects of Bevacizumab for the Treatment of Recurrent Ovarian Cancer

Journal: Current Drug Targets
Volume: 18, Issue: 10
Page: 1125-1131
Authors: Wenwen Zhang, Zhaojun Shen, Hui Luo, Xiaoli Hu, Lihong Zheng and Xueqiong Zhu*

Targeted Therapy of Ovarian Cancer with Angiogenesis Inhibitors

Journal: Current Drug Targets
Volume: 18, Issue: 10
Page: 1171-1178
Authors: Ping Duan, Lili Fan, Quansheng Gao, Bal Mukunda Silwal, Mulan Ren, Yang Shen* and Wanglei Qu*

Editorial: Drug Targets and Biomarkers for Obstetric/Gynecologic/Reproductive Diseases

Journal: Current Drug Targets
Volume: 18, Issue: 10
Page: 1113-1115
Authors: Xueqiong Zhu* and Shi-Wen Albert Jiang*

Combination Platinum-based and DNA Damage Response-targeting Cancer Therapy: Evolution and Future Directions

Journal: Current Medicinal Chemistry
Volume: 24, Issue: 15
Page: 1586-1606
Authors: Spyridon P. Basourakos, Likun Li, Ana M. Aparicio, Paul G. Corn, Jeri Kim and Timothy C. Thompson*

Liposomal Drug Delivery System for Cancer Therapy: Advancement and Patents

Journal: Recent Patents on Drug Delivery & Formulation
Volume: 10, Issue: 3
Page: 177-183
Authors: Sheetal Jha, Pramod K. Sharma and Rishabha Malviya

Indoleamine 2,3-dioxygenase (IDO): Biology and Target in Cancer Immunotherapies

Journal: Current Cancer Drug Targets
Volume: 16, Issue: 9
Page: 755-764
Authors: Senthamil R. Selvan, John P. Dowling, William K. Kelly and Jianqing Lin

Overcoming Chemotherapy Resistance in High Grade Serous Ovarian Cancer

Journal: Current Cancer Therapy Reviews
Volume: 12, Issue: 1
Page: 23-36
Authors: Raghav Sundar, David Tan, Lim S. Lei and Whay-Kuang Chia

Evolution of Chemosensitivity and Resistance Assays as Predictors of Clinical Outcomes in Epithelial Ovarian Cancer Patients

Journal: Current Pharmaceutical Design
Volume: 22, Issue: 30
Page: 4717-4728
Authors: Bradley J. Monk, Thomas J. Herzog and Krishnansu S. Tewari

P-gp Inhibition-Based Strategies for Modulating Pharmacokinetics of Anticancer Drugs: An Update

Journal: Current Drug Metabolism
Volume: 17, Issue: 8
Page: 806-826
Authors: Xiaobo Yang and Kexin Liu

Nanoliposome is a Promising Carrier of Protein and Peptide Biomolecule for the Treatment of Cancer

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 16, Issue: 7
Page: 816-831
Authors: Tapan Kumar Giri, Ayan Giri, Tapan Kumar Barman and Subhasis Maity

Treatment of High-Grade Pelvic-Type Serous Carcinomas (Ovary, Fallopian Tube and Peritoneum): Current Therapeutic Paradigms, Prospects, and Challenges

Journal: Current Cancer Therapy Reviews
Volume: 11, Issue: 4
Page: 300-313
Authors: Mary Chu, D. Stave Kohtz, Estrelania Williams, Tamara Kalir and David Fishman

Functional Link between BRCA1 and BAP1 through Histone H2A, Heterochromatin and DNA Damage Response

Journal: Current Cancer Drug Targets
Volume: 16, Issue: 2
Page: 101-109
Authors: Takayo Fukuda, Tomoko Tsuruga, Takako Kuroda, Hiroyuki Nishikawa and Tomohiko Ohta

Nanocarriers Based Anticancer Drugs: Current Scenario and Future Perceptions

Journal: Current Drug Targets
Volume: 17, Issue: 2
Page: 206-228
Authors: Rakesh Raj, Pooja Mongia, Suresh Kumar Sahu and Alpana Ram

The Epidemiological, Mechanistic and Potential Clinical Role of Androgen Receptor (AR) in Urothelial Carcinoma

Journal: Current Drug Targets
Volume: 17, Issue: 2
Page: 196-205
Authors: Maria T. Bourlon and Thomas W. Flaig

Management of Fallopian Tube Cancer

Journal: Reviews on Recent Clinical Trials
Volume: 10, Issue: 4
Page: 276-281
Authors: Shweta Rai and Amita Maheshwari

The Holy Grail of Polymer Therapeutics for Cancer Therapy: An Overview on the Pharmacokinetics and Bio Distribution

Journal: Current Drug Metabolism
Volume: 16, Issue: 7
Page: 522-537
Authors: Sathish Dyawanapelly, Vijayabhaskar Reddy Junnuthula and AkhileshVikram Singh

Editorial (Thematic Issue: Management of Gynaecological Cancers - An Update)

Journal: Reviews on Recent Clinical Trials
Volume: 10, Issue: 4
Page: 252-254
Authors: Shakuntala Chhabra

Ovarian Cancer - Angiogenesis and Targeted Therapy

Journal: Current Angiogenesis (Discontinued)
Volume: 3, Issue: 4
Page: 215-230
Authors: Kristsanamon Rittiluechai, Naiyarat Prasongsuk, Vincent Vinh-Hung and Claire Verschraegen

Editorial (Thematic Issue: Current Overview of Anti-Angiogenic Therapies for Patients with Epithelial Ovarian Cancer)

Journal: Current Angiogenesis (Discontinued)
Volume: 3, Issue: 4
Page: 175-178
Authors: Samir A. Farghaly

Novel Therapeutic Strategies For Angiogenesis Inhibition In Recurrent Ovarian Cancer

Journal: Current Angiogenesis (Discontinued)
Volume: 3, Issue: 4
Page: 179-192
Authors: Victoria L. Chiou, Elise C. Kohn, Nicole Davarpanah and Jung-Min Lee

Low Dose Decitabine Combined with Taxol and Platinum Chemotherapy to Treat Refractory/Recurrent Ovarian Cancer: An Open-Label, Single-Arm, Phase I/II Study

Journal: Current Protein & Peptide Science
Volume: 16, Issue: 4
Page: 329-336
Authors: Xiaoyu Fu, Yan Zhang, Xiaohui Wang, Meixia Chen, Yao Wang, Jing Nie, Yuanguang Meng and Weidong Han

Angiogenesis and Anti-angiogenic Therapies in Epithelial Ovarian Cancer

Journal: Current Angiogenesis (Discontinued)
Volume: 3, Issue: 2
Page: 60-65
Authors: Halima Abahssain, Sakina Sekkate, Sihame Lkhoyaali, Patricia Pautier, Hind M’Rabti and Hassan Errihani

A Novel Multiple Tyrosine-kinase Targeted Agent to Explore the Future Perspectives of Anti-Angiogenic Therapy for the Treatment of Multiple Solid Tumors: Cabozantinib

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 15, Issue: 1
Page: 37-47
Authors: Subhajit Roy, Bawneet K. Narang, Shiva K. Rastogi and Ravindra K. Rawal

Paclitaxel Formulations: Challenges and Novel Delivery Options

Journal: Current Drug Delivery
Volume: 11, Issue: 6
Page: 666-686
Authors: Chetan Nehate, Sharad Jain, Ankit Saneja, Vaibhav Khare, Noor Alam, Ravindra Dhar Dubey and Prem N. Gupta

Uncommon Becoming Common: Case Series of Primary Fallopian Tube Cancers

Journal: Current Women`s Health Reviews
Volume: 9, Issue: 4
Page: 230-234
Authors: Kalpana Ragupathy, Neelam Dugar, Perviz Iqbal and Mohammed Alloub

Biomarkers for Systemic Therapy in Ovarian Cancer

Journal: Current Cancer Drug Targets
Volume: 14, Issue: 3
Page: 259-273
Authors: Zsofia Penzvalto, Pawel Surowiak and Balazs Gyorffy

Current Protein-based Anti-angiogenic Therapeutics

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 14, Issue: 3
Page: 291-312
Authors: Sanjukta Chakrabarti, Colin J. Barrow, Rupinder K. Kanwar, Venkata Ramana and Jagat R. Kanwar

Application of dsRNA in Cancer Immunotherapy: Current Status and Future Trends

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 14, Issue: 2
Page: 241-255
Authors: Bo Jin, Liu-Fang Cheng, Kai Wu, Xiao-Hong Yu and Anthony E.T. Yeo

Monoclonal Antobodies: Application in Radiopharmacy

Journal: Current Radiopharmaceuticals
Volume: 6, Issue: 4
Page: 231-248
Authors: Thais Braga Ligiero, Marta de Souza Albernaz, Samira Marques de Carvalho, Silvia Maria Velasques de Oliveira and Ralph Santos-Oliveira

Microtubule Targeting Agents: A Benchmark in Cancer Therapy

Journal: Current Drug Therapy
Volume: 8, Issue: 3
Page: 189-196
Authors: Verma Nitika and Khatri Kapil

Advances in Anticancer Antibody-Drug Conjugates and Immunotoxins

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 9, Issue: 1
Page: 35-65
Authors: Franco Dosio, Barbara Stella, Sofia Cerioni, Daniela Gastaldi and Silvia Arpicco

Recent Development in Targeting PI3K-Akt-mTOR Signaling for Anticancer Therapeutic Strategies

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 13, Issue: 10
Page: 1552-1564
Authors: Asif Khurshid Qazi, Aashiq Hussain, Abid Hamid, Yasrib Qurishi, Rabiya Majeed, Mudassier Ahmad, Rauf Ahmad Najar, Javeed Ahmad Bhat, Shashank Kumar Singh, Mohmmad Afzal Zargar, Shakir Ali and Ajit Kumar Saxena

Activin Receptor-Like Kinase 1: a Novel Anti-angiogenesis Target from TGF-β Family

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 13, Issue: 10
Page: 1398-1406
Authors: Luca Vecchia, Carla Olivieri and Claudia Scotti

Multifunctional Anti-Cancer Nano-Platforms are Moving to Clinical Trials

Journal: Current Drug Metabolism
Volume: 14, Issue: 5
Page: 583-604
Authors: Claudio Esposito, Annalisa Crema, Antonio Ponzetto, Giovanni Murtas and Guido Carloni

Unmet Needs in Ovarian Cancer: Dividing Histologic Subtypes to Exploit Novel Targets and Pathways

Journal: Current Cancer Drug Targets
Volume: 13, Issue: 6
Page: 698-707
Authors: Vijaya Galic, Robert L. Coleman and Thomas J. Herzog

Past, Present and Future Strategies of Immunotherapy in Gynecological Malignancies

Journal: Current Molecular Medicine
Volume: 13, Issue: 4
Page: 648-669
Authors: F. Bellati, C. Napoletano, I. Ruscito, V. Visconti, M. Antonilli, M.L. Gasparri, I.G. Zizzari, H. Rahimi, I. Palaia, A. Rughetti, P. Benedetti Panici and M. Nuti

The PI3 Kinase Signaling Pathway in Prostate Cancer

Journal: Current Cancer Drug Targets
Volume: 13, Issue: 2
Page: 157-164
Authors: Aymen A. Elfiky and Zhenyang Jiang

Inhibition of RET Activated Pathways: Novel Strategies for Therapeutic Intervention in Human Cancers

Journal: Current Pharmaceutical Design
Volume: 19, Issue: 5
Page: 864-882
Authors: Libero Santarpia and Giulia Bottai

Incorporation of Anti-angiogenic Therapies in the Treatment of Epithelial Ovarian Cancer: Current Perspectives and Future Directions

Journal: Current Angiogenesis (Discontinued)
Volume: 1, Issue: 4
Page: 266-276
Authors: Ramez N. Eskander and Philip J. DiSaia

Targeting Tumor Ubiquitin-Proteasome Pathway with Polyphenols for Chemosensitization

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 12, Issue: 8
Page: 891-901
Authors: Min Shen, Tak Hang Chan and Q. Ping Dou

Antiangiogenic Drugs in the Treatment of Advanced Epithelial Ovarian Cancer

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 12, Issue: 8
Page: 982-987
Authors: Parham Khosravi-Shahi and Luis Cabezon-Gutierrez

Role of PARP Inhibitors in Cancer Biology and Therapy

Journal: Current Medicinal Chemistry
Volume: 19, Issue: 23
Page: 3907-3921
Authors: D. Davar, J. H. Beumer, L. Hamieh and H. Tawbi

Multiple VEGF Family Members are Simultaneously Expressed in Ovarian Cancer: a Proposed Model for Bevacizumab Resistance

Journal: Current Pharmaceutical Design
Volume: 18, Issue: 25
Page: 3784-3792
Authors: Arne R.M. van der Bilt, Ate G.J. van der Zee, Elisabeth G.E. de Vries, Steven de Jong, Hetty Timmer- Bosscha, Klaske A. ten Hoor, Wilfred F.A. den Dunnen, Harry Hollema and Anna K.L. Reyners

Editorial: Advances in Epithelial Ovarian Cancer Therapy

Journal: Current Pharmaceutical Design
Volume: 18, Issue: 25
Page: 3735-3740
Authors: Judith R. Kroep

Review of Dose-intense Platinum and/or Paclitaxel Containing Chemotherapy in Advanced and Recurrent Epithelial Ovarian Cancer

Journal: Current Pharmaceutical Design
Volume: 18, Issue: 25
Page: 3741-3753
Authors: Ingrid A. Boere and Maria E.L. van der Burg

The Role of Bevacizumab in Advanced Epithelial Ovarian Cancer

Journal: Current Pharmaceutical Design
Volume: 18, Issue: 25
Page: 3775-3783
Authors: Judith R. Kroep and Johan W.R. Nortier

Namitecan: a Hydrophilic Camptothecin with a Promising Preclinical Profile

Journal: Current Medicinal Chemistry
Volume: 19, Issue: 21
Page: 3488-3501
Authors: G. L. Beretta, V. Zuco, M. De Cesare, P. Perego and N. Zaffaroni

Biomarkers to Assess the Targeting of DNA Repair Pathways to Augment Tumor Response to Therapy

Journal: Current Molecular Medicine
Volume: 12, Issue: 6
Page: 788-803
Authors: S. Nowsheen, A. C. Whitley and E. S. Yang

Anti-VEGF Strategies – from Antibodies to Tyrosine Kinase Inhibitors: Background and Clinical Development in Human Cancer

Journal: Current Pharmaceutical Design
Volume: 18, Issue: 19
Page: 2680-2701
Authors: Grzegorz Korpanty and Elizabeth Smyth

Moving Beyond VEGF for Anti-angiogenesis Strategies in Gynecologic Cancer

Journal: Current Pharmaceutical Design
Volume: 18, Issue: 19
Page: 2713-2719
Authors: Duangmani Thanapprapasr, Wei Hu, Anil K Sood and Robert L Coleman

Application of Monoclonal Antibodies as Cancer Therapy in Solid Tumors

Journal: Current Clinical Pharmacology
Volume: 7, Issue: 2
Page: 137-145
Authors: Rodrigo Dienstmann, Ben Markman and Josep Tabernero

The Scatter Factor Signaling Pathways as Therapeutic Associated Target in Cancer Treatment

Journal: Current Medicinal Chemistry
Volume: 17, Issue: 25
Page: 2699-2712
Authors: P. Accornero, L.M. Pavone and M. Baratta

Mechanisms of Drug Resistance to Vascular Endothelial Growth Factor (VEGF) Inhibitors

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 10, Issue: 8
Page: 593-600
Authors: Jahan Tavakoli and Jeanny B. Aragon-Ching

Targeting mTOR Signaling Pathway in Ovarian Cancer

Journal: Current Medicinal Chemistry
Volume: 18, Issue: 19
Page: 2960-2968
Authors: S. Mabuchi, T. Hisamatsu and T. Kimura

Rheumatic Manifestations in Malignancy

Journal: Current Rheumatology Reviews
Volume: 4, Issue: 1
Page: 50-58
Authors: Eric L. Matteson and Mohannad A. Abu-Hilal

Anticancer Antifolates: Current Status and Future Directions

Journal: Current Pharmaceutical Design
Volume: 9, Issue: 31
Page: 2593-2613
Authors: John J. McGuire

Antiangiogenic Therapy and Ovarian Cancer

Journal: Current Women`s Health Reviews
Volume: 4, Issue: 1
Page: 33-44
Authors: Richard T. Penson, J. Alejandro Rauh-Hain and Neil S. Horowitz

Targeting Angiogenesis in Ovarian Carcinoma

Journal: Current Cancer Therapy Reviews
Volume: 5, Issue: 3
Page: 188-202
Authors: Marta Mendiola, Jorge Barriuso and David Hardisson

Recent Patents Reveal Microtubules as Persistent Promising Target for Novel Drug Development for Cancers

Journal: Recent Patents on Anti-Infective Drug Discovery
Volume: 4, Issue: 3
Page: 164-182
Authors: Usha Bughani, Shiwang Li and Harish C. Joshi

Angiogenesis Inhibition: State of the Art, Forgotten Strategies and New Perspectives in Cancer Therapy

Journal: Current Cancer Therapy Reviews
Volume: 5, Issue: 3
Page: 203-216
Authors: Roberto Benelli and Nicoletta Ferrari

The Emerging Role of Vascular Endothelial Growth Factor (VEGF) in Vascular Homeostasis: Lessons from Recent Trials with Anti-VEGF Drugs

Journal: Current Vascular Pharmacology
Volume: 9, Issue: 3
Page: 358-380
Authors: Shivshankar Thanigaimani, Ganessan Kichenadasse and Arduino A. Mangoni

Efficacy and Safety of the Combination of Docetaxel (Taxotere®) with Targeted Therapies in the Treatment of Solid Malignancies

Journal: Current Drug Targets
Volume: 10, Issue: 10
Page: 982-1000
Authors: Vincenzo Emanuele Chiuri, Nicola Silvestris, Andrea Tinelli and Vito Lorusso

Prophylactic Surgery to Reduce the Risk of Developing Breast Cancer:Issues and Clinical Implications

Journal: Current Women`s Health Reviews
Volume: 8, Issue: 1
Page: 94-103
Authors: Elisabetta Razzaboni, Giovanni Tazzioli, Alessia Andreotti, Elisabetta De Matteis, Laura Cortesi and Massimo Federico